296 related articles for article (PubMed ID: 29132091)
1. Effect of anti-diabetic drugs on bone metabolism: Evidence from preclinical and clinical studies.
Adil M; Khan RA; Kalam A; Venkata SK; Kandhare AD; Ghosh P; Sharma M
Pharmacol Rep; 2017 Dec; 69(6):1328-1340. PubMed ID: 29132091
[TBL] [Abstract][Full Text] [Related]
2. Update on: effects of anti-diabetic drugs on bone metabolism.
Mabilleau G; Bouvard B
Expert Rev Endocrinol Metab; 2020 Nov; 15(6):415-430. PubMed ID: 33059497
[TBL] [Abstract][Full Text] [Related]
3. Effects of diabetes drugs on the skeleton.
Meier C; Schwartz AV; Egger A; Lecka-Czernik B
Bone; 2016 Jan; 82():93-100. PubMed ID: 25913633
[TBL] [Abstract][Full Text] [Related]
4. Diabetes and bone health.
Antonopoulou M; Bahtiyar G; Banerji MA; Sacerdote AS
Maturitas; 2013 Nov; 76(3):253-9. PubMed ID: 23628280
[TBL] [Abstract][Full Text] [Related]
5. Bone health in diabetes: considerations for clinical management.
Adami S
Curr Med Res Opin; 2009 May; 25(5):1057-72. PubMed ID: 19292601
[TBL] [Abstract][Full Text] [Related]
6. Diabetes Drug Effects on the Skeleton.
Chandran M
Calcif Tissue Int; 2017 Feb; 100(2):133-149. PubMed ID: 27815568
[TBL] [Abstract][Full Text] [Related]
7. The impact of diabetes and diabetes medications on bone health.
Gilbert MP; Pratley RE
Endocr Rev; 2015 Apr; 36(2):194-213. PubMed ID: 25738213
[TBL] [Abstract][Full Text] [Related]
8. Osteoporosis and risk of fracture in patients with diabetes: an update.
Montagnani A; Gonnelli S; Alessandri M; Nuti R
Aging Clin Exp Res; 2011 Apr; 23(2):84-90. PubMed ID: 21743287
[TBL] [Abstract][Full Text] [Related]
9. Effect of Drugs Used in Pharmacotherapy of Type 2 Diabetes on Bone Density and Risk of Bone Fractures.
Wikarek A; Grabarczyk M; Klimek K; Janoska-Gawrońska A; Suchodolska M; Holecki M
Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541119
[TBL] [Abstract][Full Text] [Related]
10. [Diabetes increases the risk of fractures].
Starup-Linde J; Karahasanovic A; Vestergaard P; Eiken P
Ugeskr Laeger; 2015 Nov; 177(49):V08150663. PubMed ID: 26651553
[TBL] [Abstract][Full Text] [Related]
11. Effects of Incretin-Based Therapies and SGLT2 Inhibitors on Skeletal Health.
Egger A; Kraenzlin ME; Meier C
Curr Osteoporos Rep; 2016 Dec; 14(6):345-350. PubMed ID: 27709509
[TBL] [Abstract][Full Text] [Related]
12. Fracture risk associated with common medications used in treating type 2 diabetes mellitus.
Wolverton D; Blair MM
Am J Health Syst Pharm; 2017 Aug; 74(15):1143-1151. PubMed ID: 28743778
[TBL] [Abstract][Full Text] [Related]
13. [Antidiabetic drugs and their effect on bone].
Jackuliak P; Kužma M; Payer J
Vnitr Lek; 2017; 63(9):609-616. PubMed ID: 29120659
[TBL] [Abstract][Full Text] [Related]
14. [Diabetes Mellitus and bone metabolism].
Okazaki R
Clin Calcium; 2011 May; 21(5):669-75. PubMed ID: 21532115
[TBL] [Abstract][Full Text] [Related]
15. Effects of thiazolidinediones on bone loss and fracture.
Murphy CE; Rodgers PT
Ann Pharmacother; 2007 Dec; 41(12):2014-8. PubMed ID: 17940125
[TBL] [Abstract][Full Text] [Related]
16. Diabetes pharmacotherapy and effects on the musculoskeletal system.
Kalaitzoglou E; Fowlkes JL; Popescu I; Thrailkill KM
Diabetes Metab Res Rev; 2019 Feb; 35(2):e3100. PubMed ID: 30467957
[TBL] [Abstract][Full Text] [Related]
17. Time-dependent risk of fracture in adults with type 2 diabetes receiving anti-diabetic drug: A one-stage network meta-analysis.
Shen Y; Shi Q; Zou X; Meng W; Tian H; Du L; Li S
Diabetes Metab Res Rev; 2024 Feb; 40(2):e3780. PubMed ID: 38367257
[TBL] [Abstract][Full Text] [Related]
18. Managing and maintaining bone mineral density in diabetes patients with pharmacotherapy.
Fixen CW; Fixen DR
Expert Opin Pharmacother; 2017 Dec; 18(18):2001-2006. PubMed ID: 29172834
[TBL] [Abstract][Full Text] [Related]
19. Bone effects of glitazones and other anti-diabetic drugs.
Rejnmark L
Curr Drug Saf; 2008 Sep; 3(3):194-8. PubMed ID: 18691001
[TBL] [Abstract][Full Text] [Related]
20. The effect of thiazolidinediones on BMD and osteoporosis.
McDonough AK; Rosenthal RS; Cao X; Saag KG
Nat Clin Pract Endocrinol Metab; 2008 Sep; 4(9):507-13. PubMed ID: 18695700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
